Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vitamin E does not modify HDL-cholesterol

D R Howard, C A Rundell, J G Batsakis

    American Journal of Clinical Pathology
    |January 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Results of the randomized phase IIB ARCTIC trial of low-dose rituximab in previously untreated CLL.

    Leukemia·2017
    Same author

    Results of the randomized phase IIB ADMIRE trial of FCR with or without mitoxantrone in previously untreated CLL.

    Leukemia·2017
    Same author

    Confocal microscopy as a useful approach to describe gill rakers of Asian species of carp and native filter-feeding fishes of the upper Mississippi River system.

    Journal of fish biology·2014
    Same author

    DNA transfection of Mammalian cells using polybrene.

    Methods in molecular biology (Clifton, N.J.)·2011
    Same author

    Safety, tolerability, antiemetic efficacy, and pharmacokinetics of oral dolasetron mesylate in pediatric cancer patients receiving moderately to highly emetogenic chemotherapy.

    Journal of pediatric hematology/oncology·1999
    Same author

    Open-label comparison of the antiemetic efficacy of single intravenous doses of dolasetron mesylate in pediatric cancer patients receiving moderately to highly emetogenic chemotherapy.

    Medical and pediatric oncology·1999
    Same journal

    Invasive urothelial carcinoma in association with surface low-grade papillary urothelial carcinoma: clinical and pathologic insights from a rare entity.

    American journal of clinical pathology·2026
    Same journal

    CEACAM1 expression by immunohistochemistry in B-cell lymphomas and plasma cell myeloma.

    American journal of clinical pathology·2026
    Same journal

    Comprehensive multicriteria life cycle assessment of biopsy processing in a surgical pathology department.

    American journal of clinical pathology·2026
    Same journal

    Prognostic significance of Myb protein and its downstream target genes in lacrimal gland adenoid cystic carcinoma.

    American journal of clinical pathology·2026
    Same journal

    Mismatch repair protein "nonclassic expression loss" pattern in colorectal cancer: an important staining pattern that is not well understood.

    American journal of clinical pathology·2026
    Same journal

    Musculoskeletal pain in medical laboratory personnel: a cross-sectional study.

    American journal of clinical pathology·2026
    See all related articles

    Vitamin E supplementation did not significantly alter high-density lipoprotein (HDL) cholesterol levels in healthy volunteers. This study refutes preliminary findings suggesting a potential cardiovascular benefit from vitamin E regarding HDL cholesterol.

    Area of Science:

    • Nutritional Biochemistry
    • Cardiovascular Health Research

    Background:

    • Preliminary reports suggested vitamin E supplementation may increase high-density lipoprotein (HDL) cholesterol.
    • HDL cholesterol is inversely associated with coronary artery disease (CAD) risk, making potential HDL-raising agents significant.
    • The need for verification or refutation of vitamin E's effect on HDL cholesterol was identified.

    Purpose of the Study:

    • To investigate the effect of daily vitamin E supplementation on serum HDL cholesterol levels.
    • To determine if vitamin E therapy impacts other key lipid markers, including total cholesterol and triglycerides.

    Main Methods:

    • A study involving 39 healthy volunteers was conducted.
    • Participants received a daily dose of 600 International Units (IU) of vitamin E for 30 days.

    Related Experiment Videos

  • Serum levels of vitamin E, total cholesterol, HDL cholesterol, and triglycerides were measured.

    • Main Results:

    • No statistically significant changes in serum HDL cholesterol were observed following 30 days of vitamin E therapy.
    • Serum vitamin E levels were monitored, but specific changes in total cholesterol and triglycerides were not detailed as primary findings.

    Conclusions:

    • Daily vitamin E supplementation at 600 IU for 30 days does not significantly increase serum HDL cholesterol in this cohort.
    • The findings do not support the preliminary hypothesis that vitamin E positively impacts HDL cholesterol levels.
    • Further research may be needed to explore vitamin E's role in cardiovascular health through different mechanisms or populations.